Taking the Wegovy Pill With Other Medications: UK Guidance

Taking the Wegovy pill with other medications raises two separate questions. The first is timing: the tablet has to go down on its own, so your other morning medicines move. The second is interaction: semaglutide slows how quickly your stomach empties, and the UK product information names a few medicines that may need closer monitoring.

This guide covers what the UK Summary of Product Characteristics (SmPC) and patient leaflet for Wegovy tablets say on both. It is information only, not medical advice: the Wegovy pill (oral semaglutide) is prescription-only, and your prescriber decides how it fits with everything else you take.

Taking the Wegovy pill with other medications: the morning order

The SmPC asks for the tablet to be taken on an empty stomach after a recommended fast of at least 8 hours, swallowed whole with a sip of water (up to 120 ml). You then wait at least 30 minutes before eating, drinking or taking other oral medicines; the leaflet says waiting less than that lowers absorption. Our empty-stomach rule article explains why the routine is so strict.

In a study reported in the SmPC, taking semaglutide alongside five other tablets cut total exposure to semaglutide by 34% and the peak level by 32%. The SmPC suggests several tablets in the stomach at once interfere with absorption. One acid-reducing medicine was tested separately: omeprazole made no clinically relevant difference to semaglutide levels.

In practice, that means:

• Everything else by mouth waits. Other tablets, capsules and liquid medicines come after the 30 minutes.
• Supplements count too. Nothing but the sip of water goes in during the wait, and the NHS asks you to mention herbal remedies, vitamins and supplements to your doctor or pharmacist.

How the Wegovy pill can change other medicines

The second effect is a different matter. The SmPC says semaglutide delays gastric emptying, which may influence how other oral medicines are absorbed. It also notes that interactions with very poorly absorbed medicines (about 1% bioavailability) have not been studied.

Levothyroxine

In the SmPC, total exposure to thyroxine rose by 33% after a single dose of levothyroxine, with the peak level unchanged, and it says thyroid monitoring should be considered when the two are used together. The leaflet says your doctor may need to check your thyroid levels.

There is also a timing clash. The NHS advises taking levothyroxine on an empty stomach, 30 to 60 minutes before your first meal, any caffeinated drink or any other medicine. Both tablets, in other words, want to go first. Neither the Wegovy leaflet nor the SmPC sets out a joint schedule, so ask your prescriber or pharmacist how to arrange them.

Warfarin and similar anticoagulants

In the SmPC, semaglutide did not change warfarin levels after a single dose, and blood clotting, measured by the INR, was not affected in a clinically relevant way. However, falls in INR have been reported in people taking semaglutide with acenocoumarol, a related anticoagulant. So when semaglutide is started in someone on warfarin or a similar coumarin medicine, frequent INR monitoring is recommended. The leaflet says you may need frequent blood tests to check how quickly your blood clots. If you take a different type of blood thinner, ask whether this applies to yours.

Where the SmPC found no clinically relevant change

Exposure to rosuvastatin, a cholesterol medicine, rose by 41%, which the SmPC judges not clinically relevant because rosuvastatin has a wide margin between an effective and a harmful level. Digoxin, metformin, furosemide and a combined contraceptive pill showed no clinically relevant change. These are findings about blood levels only; the morning wait still applies.

Diabetes medicines and low blood sugar

Semaglutide lowers blood glucose. The SmPC warns that combining it with insulin or a sulfonylurea (such as gliclazide) may increase the risk of low blood sugar (hypoglycaemia), and that prescribers should consider reducing those doses when starting it. Your doctor may ask you to test your blood sugar to help decide.

• Leave dose changes to your prescriber; do not adjust diabetes medicines yourself.
• Not a replacement. Semaglutide must not be used as a substitute for insulin.
• One GLP-1 at a time. The SmPC says semaglutide should not be combined with other GLP-1 receptor agonist medicines.
• Know the warning signs. The leaflet’s list includes a cold sweat, shaking, a fast heartbeat, feeling very hungry and difficulty concentrating; do not drive if you notice them.

Contraception and pregnancy

The leaflet says the Wegovy pill should not be used in pregnancy, so you need contraception while taking it, and it should be stopped at least 2 months before a planned pregnancy. On the contraceptive pill itself, the SmPC found no clinically relevant change in levels of a combined pill containing ethinylestradiol and levonorgestrel. The MHRA’s advice to add a barrier method, such as condoms, for four weeks after starting and after each dose increase is written for people taking Mounjaro (tirzepatide); it does not name semaglutide. Its stated reason refers to GLP-1 medicines in general, so ask your prescriber or pharmacist which contraception suits you, and whether vomiting or diarrhoea affects the pill’s protection.

Anaesthetics, sedation and new prescriptions

Because semaglutide slows stomach emptying, the SmPC notes reports of stomach contents being inhaled into the lungs (pulmonary aspiration) in people on GLP-1 medicines having a general anaesthetic or deep sedation. Tell your doctor and the anaesthetist before any such procedure; the NHS includes sedation for dental work. The MHRA says not to stop your medicine without discussing it with your doctor first.

The leaflet also asks you to tell your doctor, pharmacist or nurse about any medicine you take, have recently taken or might take.

Side effects and reporting

Nausea, vomiting and diarrhoea are among the most common side effects; the leaflet warns they can cause dehydration, so drink enough fluids. Our side effects page covers the rest. The tablet is under additional monitoring, so report any suspected side effect, including a possible interaction, through the MHRA Yellow Card scheme. See the dosage page for the dose steps and our FAQ for wider questions.

Frequently asked questions

Related reading

• The Wegovy pill’s empty-stomach rule, and why it exists
• Wegovy pill missed dose: what the UK leaflet says to do
• How oral semaglutide survives the stomach: SNAC explained

This article is information only, not medical advice. The Wegovy pill is a prescription-only medicine; a qualified prescriber decides whether it is suitable for you.